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Right lower lobectomy after right upper lobectomy for
multiple metastases in lung cancer of the right lower
lobe: Benefit of middle lobe preservation
Hisashi Iwata, MD, PhD,a Takuji Kiryu, MD, PhD,b Koyo Shirahashi, MD,a
Shinsuke Matsumoto, MD,a Masafumi Matsui, MD,a and
Hirofumi Takemura, MD, PhD,a Gifu, Japan
Postoperative respiratory function is a crucialfactor when considering surgical treatment forlung cancer, particularly for relapse or secondarylung cancer. We describe herein a case of
lobectomy for multiple metastases in the right lower lobe
of the lung with preservation of the middle lobe after
initial right upper lobectomy.
Clinical Summary
A 60-year-old woman with lung cancer underwent right upper lobec-
tomy. The tumor specimen was a well-differentiated adenocarcinoma,
pathologic stage IA (T1 N0 M0). Multiple slow-growing nodules
were noted in the right lower lobe 4 years postoperatively. Recur-
rent lesions are generally multiple and disseminated, and addi-
tional surgical intervention is not usually indicated. However, no
nodules were apparent in other lobes during 1 year of follow-up.
The patient was therefore referred to our department for surgical
treatment. Routine blood biochemistry and coagulation studies
yielded normal results and carcinoembryonic antigen level was 2.6
ng/mL. A chest computed tomographic scan from 4 years earlier
showed the primary lung cancer as a solid tumor in the right upper
lobe (Figure 1, A), compared with the scan of multiple nodules
limited to the right lower lobe for the metastases (Figure 1, B).
These multiple tumors showed no uptake on a fluorodeoxyglucose
positron emission tomographic scan. Transbronchiolar lung biopsy
was not performed owing to patient refusal. No extrathoracic
metastatic lesions were identified. Preoperative forced vital capac-
ity (FVC) and forced expiratory volume in 1 second (FEV1.0) were
2420 mL and 1510 mL, respectively. We evaluated predicted
results of completion pnuemonectomy using perfusion scintigra-
phy and pulmonary artery obstruction testing. Predicted FVC and
FEV1.0 after completion pneumonectomy were 1114 mL and 695
mL, respectively. Obstruction of the right pulmonary artery
yielded a pressure of 19 mm Hg. Video-assisted right lower
lobectomy was performed, preserving the middle lobe. Adhesion
of the lower lobe to the chest wall was easily removed by the
thoracoscopic view. The middle lobe was also adherent to the chest
wall and helped to prevent middle lobe torsion. On final pathologic
examination, the specimen from the lower lobe was characteristic
of metastatic adenocarcinoma from the previous lung cancer of the
right upper lobe (Figure 1, C and D). Postoperative FVC and
FEV1.0 were 1570 mL and 1200 mL, respectively. Perfusion
scintigraphy showed 391,199 (21.7%) of 1,801,504 counts for the
preserved middle lobe (Figure 2). Respiratory function after right
upper and lower lobectomies preserved more than half of the
original respiratory function.
The postoperative course was uneventful. Chest computed to-
mographic imaging after 1 year of preservation of the middle lobe
showed adequate volume without emphysematous change. After
17 months of follow-up, the patient is doing well with no evidence
of disease or requirement for additional oxygen support.
Discussion
Martini and Melamed1 described the properties of metachronous
lung cancer such as second cancer in different lobes or lungs but
displaying the same histologic features, with neither carcinoma in
lymphatics common to both cancer nor extrapulmonary metastasis
at the time of diagnosis. However, they also mentioned that bron-
chial alveolar carcinoma or multinodular growth patterns were
arbitrarily excluded because of difficulties in ruling out airborne or
intrapulmonary lymphatic dissemination.
The lower lobe specimen displayed characteristics of metastatic
adenocarcinoma, given the distinct margin between tumor and
normal lung tissue. In addition, multiple tumors were limited to the
right lower lobe, suggesting metastases rather than metachronous
tumors. We speculated that recurrence was due to transbronchial
metastasis during upper lobectomy. From the perspective of man-
agement, differentiating between new primary tumors and recur-
rence is unimportant.2 Angeletti and associates3 showed that ag-
gressive surgical approaches are safe, effective, and warranted in
patients with second primary lung cancer or relapse from primary
lung cancer. They analyzed 19 patients with metachronous second
primary cancer and 7 patients with local relapse. However, right
upper and lower lobectomies while preserving the middle lobe
were not performed. Gugginoa and colleagues4 described postop-
erative respiratory insufficiency after completion pneumonectomy
in 26.3% of patients with lung cancer and also reported operative
mortality rates of 0% to 17.6% for cancer from several institutions.
We therefore decided to avoid completion pneumonectomy. Pres-
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Figure 1. A, Chest computed tomographic scan shows a solid, irregular mass in the right upper lobe at primary
operation. B, Chest computed tomographic scan shows multiple, slow-growing masses limited to the right lower
lobe. C, Tumor of the right upper lobe, characteristic of well-differentiated adenocarcinoma. D, A specimen from
the lower lobe shows clear margin between carcinoma and normal tissue, characteristic of metastatic adeno-
carcinoma from the primary lesion.
Figure 2. Perfusion scintigraphy of the preserved middle lobe shows a count of 391,199, indicating 21.7% residual
respiratory function. Preserved forced vital capacity (FVC), percent vital capacity (VC), and forced expiratory
volume in 1 second (FEV1.0) after right upper and lower lobectomy were at 52.7%, 58.2% and 52.5% of original
respiratory function. The chest computed tomographic image was taken 1 year after preservation of the middle
lobe.
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ervation of the middle lobe contributed substantially to postoper-
ative respiratory function (Figure 2).
Conversely, preservation of the middle lobe in the absence of
the upper and lower lobes may induce torsion. Various factors
appear to be associated with lobar torsion, including complete
interlobar fissure, absence of adhesions, a narrow middle lobe
hilum, and overzealous mobilization of the lobe.5 In our case, the
middle lobe was fixed by adhesions to the chest wall. However,
emphysematous changes in the residual middle lobe may be in-
duced owing to volume mismatch in the middle lobe and thoracic
cavity during long-term follow-up.
In conclusion, preserving the middle lobe after resection of both
upper and lower lobes offers advantages to residual respiratory func-
tion, compared with results from completion pneumonectomy.
References
1. Martini N, Melamed MR. Multiple primary lung caners. J Thorac
Cardiovascular Surg. 1975;70:606-12.
2. Deschamps C, Palrolero PC, Trastek VF, Payne WS. Multiple primary
lung cancers. J Thorac Cardiovasc Surg. 1990;99:769-78.
3. Angeletti CA, Mussi A, Janni A, Lucchi M, Ribechini A, Chella A, et
al. Second primary lung cancer and relapse: treatment and follow-up.
Eur J Cardiothorac Surg. 1995;9:607-11.
4. Gugginoa G, Doddolia C, Barlesi F, Acri P, Chetaille B, Thomas P, et
al. Completion pneumonectomy in cancer patients: experience with 55
cases. Eur J Cardiothorac Surg. 2004;25:449-55.
5. Apostolakis E, Koletsis EN, Panagopoulos N, Prokakis C, Dougenis
D. Fatal stroke after completion pneumonectomy for torsion of left
upper lobe following left lower lobectomy. J Cardiothorac Surg.
2006;1:25.
Fibroepithelial polyps: Preoperative diagnosis
may avoid thoracotomy
Christopher T. Wartmann, MD,a,b Denise Fernandez, BA,b and Raja M. Flores, MD,b
Chicago, Ill, and New York, NY
We present the case of a 32-year-old man whopresented with an indeterminate obstructing lunglesion thought to be malignant. Thoracotomy re-vealed the lesion to be a benign fibroepithelial
polyp of the bronchus. Had this diagnosis been entertained preop-
eratively, thoracotomy might have been avoided.
Clinical Summary
This construction worker with a medical history consisting of
smoking 1 pack of cigarettes per day for 16 years presented to his
general practitioner and was treated for asthma and recurrent
pneumonia. A chest radiograph taken at this time showed minimal
lower lobe subsegmental atelectatic changes along with a mild
degree of perihilar pulmonary vascular congestion. A chest com-
puted tomographic (CT) scan demonstrated a 3-cm mass occluding
the left mainstem bronchus, extending into the left upper and lower
lobe bronchi (Figure 1). A positron emission CT scan illustrated no
lymphadenopathy, and
no fluorodeoxyglucose
accumulation was seen
in the left endobron-
chial lesion.
The patient under-
went rigid broncho-
scopic scanning, where
the lesion within the
left mainstem bronchus
was identified. The le-
sion side underwent biopsy multiple times; pathology showed
benign squamous mucosa with extensive submucosal fibrosis and
mild chronic inflammation, with no tumor seen. An attempt was
made at coring out this lesion. However, in lieu of radiographic
evaluation and demarcation, it was deemed unsafe to remove at
this time because of the potential for pulmonary artery invasion;
therefore aggressive coring out by means of rigid bronchoscopy
could result in significant hemorrhage. Thus thoracotomy was
scheduled because of fear of a missed malignant diagnosis caused
by the lesion’s extensive nature and to avoid potential hemorrhage
caused by performing aggressive rigid bronchoscopy. A left pos-
terolateral thoracotomy was performed, and the lung was inspected
without any evidence of parenchymal lesions. A bronchotomy was
made in the orifice of the left upper lobe bronchus. A significant
amount of endobronchial lesion was removed in a piecemeal
fashion. This was a lobulated, multiseptated, fleshy lesion slightly
larger than a golf ball that continued down into the left upper and
lower lobes (Figure 2). On closer inspection, the lesion was ad-
herent to a segmental bronchus down in the left lower lobe by a
single stalk; a frozen section was determined to be benign. The
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